Trial Profile
Phase II trial to study the tolerability and the effectiveness of imatinib in patients with chronic myelogenous leukemia in chronic phase in relapse after allogeneic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2005 New trial record.